Investing.com - Financial Markets Worldwide
⚠ Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Lloyds Bank loss hits FTSE 100, AstraZeneca gains

Published 07/30/2020, 03:24 PM
Updated 07/30/2020, 03:30 PM
UK100
-
LLOY
-
AZN
-
INCH
-
FTMC
-
FTNMX401010
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 down 0.4%, FTSE 250 off 0.3%

July 30 (Reuters) - Gloomy quarterly results from Lloyds
Bank and a clutch of other companies led the FTSE 100 lower on
Thursday, while AstraZeneca rose after topping analysts'
expectations on the back of strong drug sales during
coronavirus-driven lockdowns.
The blue-chip FTSE 100 .FTSE was down 0.4%, with Lloyds
Banking Group LLOY.L sliding 5.9% after swinging to a rare
pretax loss in the first half of 2020 due to
higher-than-expected loan loss provisions. The mid-cap FTSE 250 .FTMC slipped 0.3%, led by a 2.4%
fall for car dealer Inchcape INCH.L as it said it also posted
a pretax loss in the first half of the year.
The autos index .FTNMX3350 was among the biggest decliners
in early trading, extending losses for the year to nearly 50% as
the COVID-19 pandemic hammers car sales in the UK. Data on
Thursday showed British car output fell by more than an annual
40% in the first six months to the lowest level since 1954.
AstraZeneca AZN.L rose 1.8% as it beat second-quarter
sales and profit estimates and backed its 2020 forecasts, helped
by strong sales of a diverse product range that now includes a
potential coronavirus vaccine.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.